Option Care Health (OPCH) Goldman Sachs 45th Annual Global Healthcare Conference summary

Operational performance and market trends

• Demonstrated resilience and strong performance despite industry disruptions, particularly the Change Healthcare issue, with expectations to resolve related challenges by year-end.

• Continued top-line growth over the past three years, driven by increased demand for home and alternate site infusions, especially for immunocompromised and medically complex patients.

• Ongoing migration of infusion therapies from hospitals and physician offices to home and infusion centers, supported by payer focus on total cost of care and medical loss ratios.

• Broader acceptance of home and infusion suite care post-COVID, with opportunities to take market share from over 800 home infusion providers.

• Growth supported by both capturing share and introducing new, limited distribution products for rare and orphan diseases.

Innovation and product pipeline

• Robust pipeline of infused drugs in phase 2 and 3 trials, with particular attention to Alzheimer's and oncology therapies.

• Conservative approach to Alzheimer's therapies, monitoring adoption as products move from academic centers to broader settings.

• Oncology seen as a significant future growth area, with strategies to align resources and leverage clinical competencies.

• Existing portfolio, especially chronic inflammatory disease and IG products, continues to drive growth, with slower but steady contributions from antibiotics and nutrition support.

Risk management and competitive landscape

• Proactive management of biosimilar and subcutaneous product introductions, with a diversified and balanced revenue base.

• No expectation of increased headwinds from biosimilars or sub-Q therapies beyond historical experience.

• Highly competitive market, with payer-owned and managed care players expanding, but strong positioning due to scale, access, quality, and patient satisfaction.

• Over 800 payer relationships and 1,400 contracts, facilitating broad network access and referral responsiveness.